AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 32855225
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation powder (TIP) - 84 mg (3 capsules once daily)
Trial: 32855225
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation powder (TIP) - 140 mg (5 capsules once daily)
Trial: 32855225
Drug: Tobramycin inhalation
RxNorm normalized name: Tobramycin Inhalation Powder
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycin inhalation powder (TIP) - 224 mg (4 capsules twice daily)
Trial: 32855225
Drug: Overall TIP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall TIP (all doses)
Trial: 35238960
Drug: Ivabradine 5
RxNorm normalized name: ivabradine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivabradine 5 mg twice daily for 3 months
Trial: 34031056
Drug: Afatinib (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Afatinib (40 mg orally once daily)
Trial: 34031056
Drug: Afatinib +
RxNorm normalized name: Afatinib
DrugBank: Afatinib (DB08916)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Afatinib + Cetuximab (Cetuximab 250 mg/m² on day 15 of cycle 1, then every 2 weeks at 500 mg/m² for 6 months)
Trial: 32807092
Drug: Short-duration antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-duration antibiotic therapy (7 days) after catheter removal
Trial: 32807092
Drug: Long-duration antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-duration antibiotic therapy (≥14 days)
Trial: 33293152
Drug: Vasopressor administration
RxNorm normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vasopressor administration (N = 16)
Trial: 33293152
Drug: No vasopressor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No vasopressor administration (N = 36)
Trial: 33293152
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose vitamin C (HDVC) administration
Trial: 33293152
Drug: 5% albumin
RxNorm normalized name: Flexbumin 5% Albumin (Human) Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% albumin (Alb) administration
Trial: 33291053
Drug: Peripheral parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peripheral parenteral nutrition (P‐PN) including lipid emulsion (17% SMOFlipid® lipid)
Trial: 33080839
Drug: Weekly high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly high-dose oral vitamin D supplementation
Trial: 33080839
Drug: Daily high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily high-dose oral vitamin D supplementation
Trial: 34498980
Drug: Dapivirine Gel
RxNorm normalized name: dapivirine
DrugBank: Dapivirine (DB08639)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapivirine Gel (0.05%)
Trial: 35925745
Drug: Supportive Treatment
RxNorm normalized name: Performax Salt Supportive Cream Base for Compounding
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive Treatment (ST)
Trial: 34078324
Drug: Supportive-Expressive Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive-Expressive Treatment (SET)
Trial: 34385241
Drug: Enzalutamide monotherapy
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Enzalutamide monotherapy
Trial: 33028197
Drug: Sufentanil (TCI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (TCI Cet 0.48 ng ml‐1)
Trial: 35183892
Drug: Prostacyclin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostacyclin infusion (1 ng/kg/min)
Trial: 35183892
Drug: Prostacyclin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostacyclin infusion and Placebo
Trial: 35144596
Drug: Canagliflozin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin (100 mg/qd)
Trial: 35144596
Drug: Metformin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1000 mg/bid)
Trial: 34275768
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate 50 mg once a day for 6 months
Trial: 38114794
Drug: Oral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral glutamine supplementation
Trial: 35438179
Drug: Oral CBD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral CBD
Trial: 35438179
Drug: Epidiolex (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidiolex (oral formulation)
Trial: 35438179
Drug: Capsule (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule (oral formulation)
Trial: 35438179
Drug: Syrup (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syrup (oral formulation)
Trial: 35363951
Drug: Active-treatment group
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active-treatment group (antihypertensive medications recommended for use in pregnancy)
Trial: 35363951
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment unless severe hypertension developed)
Trial: 35363951
Drug: Active-treatment group
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active-treatment group
Trial: 33711180
Drug: Felcisetrag 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felcisetrag 0.1 mg
Trial: 33711180
Drug: Felcisetrag 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felcisetrag 0.3 mg
Trial: 33711180
Drug: Felcisetrag 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felcisetrag 1.0 mg
Trial: 33711180
Drug: Felcisetrag (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felcisetrag (all doses)
Trial: 36126241
Drug: Evobrutinib 25
RxNorm normalized name: Evobrutinib
DrugBank: Evobrutinib (DB15170)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evobrutinib 25 mg once-daily (q.d.)
Trial: 36126241
Drug: Evobrutinib 75
RxNorm normalized name: Evobrutinib
DrugBank: Evobrutinib (DB15170)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evobrutinib 75 mg once-daily (q.d.)
Trial: 36126241
Drug: Evobrutinib 75
RxNorm normalized name: Evobrutinib
DrugBank: Evobrutinib (DB15170)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evobrutinib 75 mg twice-daily (b.i.d.)
Trial: 36126241
Drug: Evobrutinib 45
RxNorm normalized name: Evobrutinib
DrugBank: Evobrutinib (DB15170)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evobrutinib 45 mg twice-daily (b.i.d.) with food
Trial: 35819090
Drug: Suspension Training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension Training System (STS)
Trial: 35422023
Drug: Selective serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective serotonin reuptake inhibitors (SSRIs) including citalopram, paroxetine, and sertraline
Trial: 35253598
Drug: Fluconazole 200
RxNorm normalized name: fluconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole 200 mg + Gentian Violet
Trial: 34258468
Drug: Propolis 500
RxNorm normalized name: propolis 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propolis 500 mg twice a day for 3 months
Trial: 34258468
Drug: Placebo 500
RxNorm normalized name: placebo 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 500 mg twice a day for 3 months
Trial: 32690834
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (topical + systemic, 800 mg/day)
Trial: 32690834
Drug: Curcumin (topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (topical + systemic, 950 mg/day)
Trial: 32690834
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (green tea extract + curcumin)
Trial: 36339547
Drug: Alfentanil (10–25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (10–25 μg/kg) combined with a fixed low dose of midazolam
Trial: 36339547
Drug: Midazolam (fixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (fixed low dose)
Trial: 32125434
Drug: MenACWY-Conjugate vaccine
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MenACWY-Conjugate vaccine
Trial: 32125434
Drug: MenACWY-Polysaccharide vaccine
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MenACWY-Polysaccharide vaccine
Trial: 32125434
Drug: Both vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both vaccines (MenACWY-Conjugate and MenACWY-Polysaccharide)
Trial: 34873992
Drug: Plyometric Training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plyometric Training (PT) - two weekly sessions for eight weeks
Trial: 34974559
Drug: Instrument-assisted soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instrument-assisted soft tissue mobilization along with routine physical therapy
Trial: 34974559
Drug: Both techniques
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both techniques (Instrument-assisted soft tissue mobilization and Routine physical therapy)
Trial: 34013559
Drug: Adlerian therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adlerian therapy (AT)
Trial: 33118194
Drug: PPE 25
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PPE 25 mg/kg body weight
Trial: 33118194
Drug: PPE 50
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PPE 50 mg/kg body weight
Trial: 33118194
Drug: PPE treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPE treatments (both doses)
Trial: 36336899
Drug: Concurrent chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiation
Trial: 35877104
Drug: Disease-Modifying Treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-Modifying Treatments (DMTs)
Trial: 34358723
Drug: Extra-Virgin Olive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-Virgin Olive Oil (EVOO) 25 mL/d for 52 days
Trial: 34358723
Drug: Sunflower oil
RxNorm normalized name: Sunflower Oil
DrugBank: Sunflower oil (DB14329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunflower oil (control) 25 mL/d for 52 days
Trial: 32520410
Drug: SAR247799 (2.5–37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAR247799 (2.5–37.5 mg single dose)
Trial: 32520410
Drug: SAR247799 (0.5–15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAR247799 (0.5–15 mg once-daily for 2 weeks)
Trial: 32520410
Drug: SAR247799 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAR247799 (10 mg)
Trial: 32520410
Drug: SAR247799 (≤5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SAR247799 (≤5 mg)
Trial: 35699623
Drug: MEDI0562 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI0562 + durvalumab (7.5 mg MEDI0562 + 1,500 mg durvalumab)
Trial: 35699623
Drug: MEDI0562 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEDI0562 + tremelimumab (22.5 mg MEDI0562 + 225 mg tremelimumab)
Trial: 34822784
Drug: HTL9936, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTL9936, a muscarinic M1 receptor agonist, designed for cognitive loss in Alzheimer's disease.
Trial: 32897014
Drug: Phenazopyridine 200
RxNorm normalized name: phenazopyridine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenazopyridine 200 mg administered 20 minutes before cystoscopy and then 200 mg every 8 hours (total three doses) with lidocaine gel
Trial: 32897014
Drug: Phenazopyridine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenazopyridine with lidocaine gel
Trial: 34127014
Drug: BA (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BA (5.0 g·day‐1 of β‐alanine)
Trial: 34127014
Drug: ALK (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALK (0.07 g·kgFFM‐1·day‐1 of sodium bicarbonate)
Trial: 36322882
Drug: Smartphone problem-solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smartphone problem-solving therapy and behavioral activation apps
Trial: 32440638
Drug: Combination antiretroviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination antiretroviral therapy (cART)
Trial: 33244655
Drug: Conventional fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fluid treatment
Trial: 34583344
Drug: Azithromycin (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (single oral dose)
Trial: 32606341
Drug: Statistical mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statistical mechanical approach for ensembles of time series designed to preserve statistical properties of empirical time series; specific dosage and duration not available.
Trial: 32606341
Drug: Unsupervised, data‐driven
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unsupervised, data‐driven framework for hypothesis testing; specific dosage and duration not available.
Trial: 34291443
Drug: Placebo (starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (starch capsules)
Trial: 36709275
Drug: BI 425809
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 425809 10 mg
Trial: 36709275
Drug: BI 425809
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 425809 25 mg
Trial: 36709275
Drug: BI 425809
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 425809 2 mg
Trial: 36709275
Drug: BI 425809
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 425809 5 mg
Trial: 35273051
Drug: Mobile Integrated
RxNorm normalized name: Chamaemelum nobile extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile Integrated Health (MIH) intervention which includes home visits from a community paramedic and telehealth video visits by emergency medicine physicians.
Trial: 33463428
Drug: Combined ACL
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined ACL reconstruction and ALL suture tape augmentation (Group 2, n=30)
Trial: 32736542
Drug: Wait-list control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wait-list control group (usual care during chemotherapy and aerobic exercise post-chemotherapy)
Trial: 34842950
Drug: Docetaxel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Docetaxel (75 mg/m2/cycle, every 3 weeks, up to 10 cycles)
Trial: 34351460
Drug: Mesenchymal stem
RxNorm normalized name: Human mesenchymal stem cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesenchymal stem cell therapy (180,000 ± 35,000 cells injected)
Trial: 36943254
Drug: Typhoid vaccine
RxNorm normalized name: Typhoid vaccine
DrugBank: Typhoid vaccine (DB14022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typhoid vaccine
Trial: 33544759
Drug: Infant nevirapine
RxNorm normalized name: Nevirapine
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infant nevirapine prophylaxis (no maternal antiretroviral therapy)
Trial: 32124574
Drug: Milieu Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milieu Therapy and routine hospital treatment
Trial: 32124574
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment in the hospital
Trial: 35774395
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (200,000 IU intramuscular cholecalciferol)
Trial: 35774395
Drug: Oral vancomycin
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral vancomycin (control)
Trial: 35319844
Drug: He's santong
FDA approved: no
EMA approved: no
PMDA approved: no
Description: He's santong acupuncture therapy
Trial: 33124506
Drug: Intensified Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified Oral Hygiene Care (IOHC)
Trial: 33124506
Drug: Routine Oral
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine Oral Hygiene Care (Control)
Trial: 37948286
Drug: Precision nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Precision nutrition counseling (six weekly sessions)
Trial: 33064852
Drug: Rectal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal misoprostol (preoperative)
Trial: 32406112
Drug: linaclotide (290
FDA approved: no
EMA approved: no
PMDA approved: no
Description: linaclotide (290 µg)
Trial: 33909985
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment by an occupational therapist
Trial: 34995417
Drug: GSK3640254 tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK3640254 tablet formulation 200 mg
Trial: 34995417
Drug: GSK3640254 tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK3640254 tablet formulation 200 mg under high-fat conditions
Trial: 33155849
Drug: Diclofenac (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (any formulation)
Trial: 34687253
Drug: LL-37 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LL-37 at 0.5 mg/mL
Trial: 34687253
Drug: LL-37 at
RxNorm normalized name: AT-III
DrugBank: Antithrombin III human (DB11598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LL-37 at 1.6 mg/mL
Trial: 33530828
Drug: Notched peripheral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Notched peripheral intravenous catheter
Trial: 34848294
Drug: Pharmacist-facilitated antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-facilitated antibiotic timeout
Trial: 616118509
Drug: Intravitreal bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal bevacizumab (IVB; 1.5 mg/0.06 cc)
Trial: 616118509
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab (IVR; 0.5 mg/0.06 cc)
Trial: 33206794
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) 150mg, two tablets daily
Trial: 33080486
Drug: Single-dose metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose metronidazole (MTZ)
Trial: 33934474
Drug: Gel cream
RxNorm normalized name: Versigel Cream for Compounding
DrugBank: Sepia esculenta bone (DB16562)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel cream containing piroctone olamine, biosaccharide gum-2, stearyl glycyrrhetinate, and zinc l-pyrrolidone carboxylate, applied twice daily for 30 days
Trial: 36448321
Drug: Microemulsion gel
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microemulsion gel formula (288 mg α-tocopherol)
Trial: 36448321
Drug: Dry solid
RxNorm normalized name: Corydalis solida whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry solid tablet (288 mg α-tocopherol)
Trial: 34710946
Drug: Sucrosomial iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrosomial iron (60 mg/day for one month)
Trial: 34958092
Drug: 3.5 g
RxNorm normalized name: Calcium 760 MG/3.5 GM Oral Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g of MCH applied as SPLAT MCH (SPLAT3.5)
Trial: 34958092
Drug: 3.5 g
RxNorm normalized name: Calcium 760 MG/3.5 GM Oral Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g of Acer kairomone blend (AKB)
Trial: 34958092
Drug: 3.5 g
RxNorm normalized name: Calcium 760 MG/3.5 GM Oral Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g of acetophenone + green leaf volatiles (PLUS)
Trial: 34958092
Drug: 7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 g of MCH applied as SPLAT MCH (SPLAT7)
Trial: 34958092
Drug: 7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 g of Acer kairomone blend (AKB)
Trial: 34958092
Drug: 7 g
RxNorm normalized name: Vaporizer 1.7 gallon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 g of acetophenone + green leaf volatiles (PLUS)
Trial: 36307156
Drug: Recruitment manoeuvres
RxNorm normalized name: Humanized Bi-Specific Xmab(R) T Cell Recruiting Antibody Construct Directed Against Cd3 And Cd38
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recruitment manoeuvres (RMs) with sequential high-flow nasal oxygen therapy (HFNO) after extubation
Trial: 34708255
Drug: 50 μg
RxNorm normalized name: penicillin G 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg lysergic acid diethylamide (LSD)
Trial: 32443412
Drug: Fortified complementary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified complementary food supplements (CFSs)
Trial: 34091488
Drug: Oral insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral insulin